Recommendation: Speculative Buy
| Entry Date | Symbol | Recommendation | Entry Price (USD) | Target 1 (USD) | Target 2 (USD) | Holding Duration | Potential Upside |
|---|---|---|---|---|---|---|---|
| 30 Oct, 24 | OSCR | Speculative Buy | USD 16.77 | USD 18.2 | USD 19.4 | 5 days | 15.7% |
Data Powered by EOD Historical Data (“EODHD”).
Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Increaased Shareholders' Wealth: Pretax ROE of 19.4% in Q1 FY24 vs Industry Median of 4.6%
Lower Credit Risk Exposure: Debt-Equity of 0.29x in Q1 FY24 vs Industry Median of 0.32x
Higher Loss Ratio: 74.2% in Q1 FY24 vs Industry Median of 62.6%
Lower Investment Ratio: 2.3% in Q1 FY24 vs Industry Median of 11.1%
Limited Geographic Reach, Scaling Challenges, Dependence on ACA, Loss Ratios, Customer Acquisition Costs, etc.
| Entry Price | Support* | Target 1 | Target 2 |
|---|---|---|---|
| 16.77 | 14.75 | 18.2 | 19.4 |
Data Source: REFINITIV, Analysis: StockNextt
*Support can be considered as an indicative stop-loss, and if prices move below that level on closing basis individuals may evaluate exiting the position depending on their risk appetite, previous holdings, and other factors considered. The support and resistance levels may need to be re-evaluated within 4-6 weeks’ time frame depending on the stock price movements from the date of recommendation on the stock.
OSCR's share price has shown support at significant levels and has begun to rise, indicating potential for short-term gains. The daily chart reveals that the 14-period RSI (Relative Strength Index) is rebounding from lower levels, reinforcing a positive outlook. Additionally, trading volumes seem to back this upward trend. Furthermore, the stock price is close to reclaiming its 21-day Simple Moving Average (SMA); once it does, it could attract more buying interest.
As per the above-mentioned technical indicators analysis, a ‘Speculative Buy’ rating has been given to Oscar Health Inc (NYSE: OSCR) at the current market price of USD 16.77 as of 30 October 2024 at 11:10 AM PDT.
Data Powered by EOD Historical Data (“EODHD”).
Sector: Healthcare Industry: Healthcare Plans
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | |
|---|---|---|---|---|---|---|---|---|
| OSCR Oscar Health Inc |
-0.715 5.07% | 13.38 | - | - | 0.37 | 1.98 | 0.13 | |
| UNH UnitedHealth Group Incorporated |
0.01 0.002% | 500.14 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
| ELV Elevance Health Inc |
0.70 0.19% | 366.66 | 18.00 | 12.66 | 0.65 | 2.87 | 0.74 | |
| CVS CVS Health Corp |
-0.675 1.52% | 43.69 | 12.06 | 9.08 | 0.29 | 1.34 | 0.47 | 8.96 |
| CI Cigna Corp |
-3.06 1.10% | 273.86 | 30.25 | 10.09 | 0.39 | 2.10 | 0.50 |
Data Powered by EOD Historical Data (“EODHD”).
Related Risks: This report may be looked at from high-risk perspective and recommendations are provided are for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is October 30, 2024 (11:10 am PDT). The reference data in this report has been partly sourced from REFINITIV.
Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Target: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Target 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Target 2 may act as the crucial resistance level for the stock.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer :
This report has been issued by StockNextt which has an Ontario Business Identification Number 1000958347 and British Columbia registration Number FM1051529 is a trade name under Kalkine Canada Advisory Services Inc. having Business Number 761925130BC0001. Kalkine Canada Advisory Services Inc. and StockNextt are collectively referred to as “StockNextt”, “we”, “us”, and “our”. The website https://stocknextt.com and associated pages are published by StockNextt. The information in this report and on the StockNextt website has been prepared from a wide variety of sources, which StockNextt, to the best of its knowledge and belief, considers accurate. StcokNextt has made every effort to ensure the reliability of information contained in its reports, newsletters, and websites. All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations for investing in securities and other financial products. StockNextt does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. StockNextt does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. StockNextt’s general advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested. Please also read our Terms and conditions for further information. Employees and/or associates of StockNextt and its related entities may hold an interest in the securities or other financial products covered in this report or on the StockNextt website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Copyright © 2023 Krish Capital Pty Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.
